Holen Sie sich die Stockscreener-App
0.6668
0.92%
-0.0062
Handel nachbörslich:
.67
0.0032
+0.48%
Lantern Pharma Inc Aktie (LTRN) Neueste Nachrichten
A reported Lantern Pharma (LTRN) stake includes 212,554 shares issuable through warrants. - Stock Titan
Form PRE 14A LANTERN PHARMA INC. For: 10 October By Investing.com - Investing.com South Africa
Lantern Pharma Schedules Virtual 2026 Annual Meeting with Seven Key Proposals on December 1 - Kalkine Media
With 281,597 shares unissued and unreserved, Lantern Pharma (LTRN) proposes a higher share limit. - Stock Titan
More than half of Taiwan’s lung cancer patients never smoked. A trial site there is screening patients. - Stock Titan
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance Australia
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance UK
After 30 business days below Nasdaq's value minimum, Lantern Pharma (NASDAQ: LTRN) has time to comply. - Stock Titan
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - BioSpace
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com South Africa
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com Canada
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com Nigeria
Lantern Pharma closes $4 million stock offering - Investing.com
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com India
Lantern Pharma Raises $4.0 Million in Registered Direct; Issues Warrants, Engages Rodman & Renshaw - TradingView
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com UK
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - Business Wire
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com South Africa
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com Nigeria
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com Canada
Lantern Pharma raises $4M in registered direct offering - Investing.com
Lantern Pharma announces up to $8M registered direct offering - TradingView
Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering - Business Wire
Lantern Pharma Inc. (LTRN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com Nigeria
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com India
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com UK
Form 8K Lantern Pharma Inc For: 23 September By Investing.com - Investing.com Nigeria
Form 8K Lantern Pharma Inc For: 23 September By Investing.com - Investing.com UK
A cancer drug could gain patent protection through 2042. Lantern Pharma’s LP-284 targets two blood cancers. - Stock Titan
Lantern Pharma Inc (NASDAQ: LTRN) Share Price, LTRN Stock News, LTRN Share Price & Updates - kalkine.ca
Lantern Pharma Q2 2026 Earnings Call: Complete Transcript - benzinga.com
Lantern Pharma Share PriceLTRN, RNS News, Articles, Quotes, & Charts (NASDAQ:LTRN) - Proactive financial news
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - guardonline.com
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - 富途牛牛
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - Yahoo Finance
Lantern Pharma Inc. (LTRN) Stock Price & News - Syfe
Lantern Pharma Earnings Call: AI Spinout, Trial Momentum - TipRanks
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript - AOL.com
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Here's Why We're A Bit Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation - Sahm
Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI - GuruFocus
Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI-Driven Pipeline Advances Amid ... - Yahoo Finance
Lantern Pharma Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Lantern Pharma Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:LTRN) 2026-08-17 - Seeking Alpha
Lantern Pharma (LTRN) Slides 2.26% as Biotech Stock Approaches Critical $2.46 SupportKey Reversal Day - vinanet.vn
Lantern Pharma (LTRN) Updates Trial Design Amid Cash Raise; Mark - GuruFocus
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceBull Pennant - vinanet.vn
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceFRAMA Signal - dars.gov.et
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceVolume Profile - careplusvn.com
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):